During the past decade, CNS Healthcare conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 12 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 10 clinical trials were completed. i.e. 43.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CNS Healthcare" #1 sponsor was "Pfizer" with 6 trials, followed by "Supernus Pharmaceuticals, Inc." with 5 trials sponsored, "BioNTech SE" with 4 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored and "Satsuma Pharmaceuticals, Inc." with 3 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CNS Healthcare" #1 collaborator was "Pfizer" with 4 trials as a collaborator, "APCER Life Sciences" with 1 trials as a collaborator, "CoLucid Pharmaceuticals" with 1 trials as a collaborator, "Cognitive Research Corporation" with 1 trials as a collaborator and "Daré Bioscience, Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "CNS Healthcare" are "COVID-19" (4 trials), "Major Depressive Disorder" (4 trials), "Migraine" (4 trials), "SARS-CoV-2 Infection" (4 trials) and "Attention Deficit Hyperactivity Disorder (ADHD)" (3 trials). Many other conditions were trialed in "CNS Healthcare" in a lesser frequency.

Most popular intervention types in "CNS Healthcare" are "Drug" (34 trials), "Biological" (7 trials), "Other" (4 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "BNT162b2" (3 trials), "Dihydroergotamine" (3 trials), "ADT" (2 trials) and "OPC-34712" (2 trials). Other intervention names were less common.

The vast majority of trials in "CNS Healthcare" are 40 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "CNS Healthcare". undefined are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in CNS Healthcare, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in CNS Healthcare, 1 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".